Literature DB >> 35095136

Recurrent Branch Retinal Artery Occlusions Revealing Susac's Syndrome.

Rim Kahloun1, Salim Ben Yahia1, Dorra Braham2, Saber Chebel3.   

Abstract

We report a case of a 28-year-old otherwise healthy female patient who presented with blurred vision in her right eye related to multiple branch retinal artery occlusions confirmed by fluorescein angiography. Investigation revealed positive antinuclear antibodies and an interatrial septal aneurysm on transthoracic echocardiography. The patient was treated with oral prednisolone and aspirin. Two months after her initial presentation, she developed hearing loss and tinnitus. Ophthalmological examination revealed temporal inferior and nasal inferior branch retinal artery occlusions in the left eye. Magnetic resonance imaging of the brain showed multifocal T2 hyperintense lesions in cortical and subcortical areas as well as the corpus callosum consistent with Susac's syndrome. The diagnosis of Susac's syndrome should be kept in mind in young patients presenting with multiple or recurrent retinal artery occlusions even in the absence of associated systemic symptoms to not delay appropriate management.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Susac’s syndrome; branch retinal artery occlusion; immunosuppressive therapy

Year:  2021        PMID: 35095136      PMCID: PMC8794251          DOI: 10.1080/01658107.2021.1887286

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  3 in total

1.  SUSAC SYNDROME.

Authors:  Kevin H Patel; Sara J Haug; Richard K Imes; Emmett T Cunningham; H Richard McDonald
Journal:  Retin Cases Brief Rep       Date:  2015

Review 2.  RECURRENT BRANCH RETINAL ARTERY OCCLUSION FROM SUSAC SYNDROME: CASE REPORT AND REVIEW OF LITERATURE.

Authors:  Michael J Ammar; Anton M Kolomeyer; Nirali Bhatt; Madhura A Tamhankar; Michael T Mullen; Alexander J Brucker
Journal:  Retin Cases Brief Rep       Date:  2020

Review 3.  Review of Susac syndrome.

Authors:  Ratna K Bitra; Eric Eggenberger
Journal:  Curr Opin Ophthalmol       Date:  2011-11       Impact factor: 3.761

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.